Found 7 matching trials
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer PHASE1 The objective of the proposed clinical trial is to investigate the safety a...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Learn More & Join Trial
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma PHASE1 This is a dual arm, open label phase I/II study to evaluate the safety and ...
Show More Location
Lombardi Comprehensive Cancer Center
Learn More & Join Trial
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC PHASE2 This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Show More Learn More & Join Trial
Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers PHASE2 Background:
Metastatic or refractory/recurrent small bowel and colorectal ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT) PHASE1 Background:
Combination immunotherapy techniques are being explored to imp...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer PHASE2 Background:
Some people with prostate cancer have a rise in prostate-speci...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer PHASE2 This is a Phase 2, single-arm, multi-institutional clinical trial designed ...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Learn More & Join Trial